CMRX - CHIMERIX INC

QQQ $ 482.11 $ 0.99 (0.21 %)

DIA $ 408.83 $ -0.40 (-0.1 %)

SPY $ 560.37 $ 0.44 (0.08 %)

TLT $ 98.96 $ 0.28 (0.28 %)

GLD $ 231.98 $ 0.32 (0.14 %)

Previous Close

$ 1.06

Open

$ 1.01

Bid

$ 1.06 x 134

Ask

$ 1.07 x 100

Day's Range

$ 1.01 - $ 1.16

52 Week Range

$ 0.75 - $ 1.30

Volume

2,129,616

Average Volume

Market Cap

95.01M

Beta (5Y Monthly)

$ 1.35

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-01-2024	03-31-2024	10-Q
3	02-29-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-02-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-16-2022	03-31-2022	10-Q
11	03-01-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	02-25-2020	12-31-2019	10-K
20	11-05-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	03-05-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-08-2018	06-30-2018	10-Q
26	05-07-2018	03-31-2018	10-Q
27	03-01-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-07-2017	06-30-2017	10-Q
30	05-09-2017	03-31-2017	10-Q
31	03-02-2017	12-31-2016	10-K
32	11-07-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-09-2016	03-31-2016	10-Q
35	02-29-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	03-06-2015	12-31-2014	10-K
40	11-07-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Africa CDC Director General Says Mpox Vacc...
08/20/2024 14:01:11

- Reuters

Vaccine Group Gavi Says It Has Up To $500M...
08/15/2024 17:02:57

- Reuters

WHO Says Actively Engaging With Swedish He...
08/15/2024 16:52:17

- Reuters

HC Wainwright & Co. Reiterates Buy on Chim...
08/14/2024 18:39:15

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

WHO Says Expert Committee Will Propose Ado...
08/14/2024 17:55:52

- Reuters

WHO Director-General Tedros Adhanom Ghebre...
08/14/2024 17:27:30

https://x.com/i/broadcasts/1kvJpbgRNWgKE

WHO Press Conference On Potential Mpox Eme...
08/14/2024 17:25:05

https://x.com/i/broadcasts/1kvJpbgRNWgKE

Chimerix Q2 2024 GAAP EPS $(0.23), Inline,...
08/13/2024 11:05:15

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.23) per share which met the analyst consensus estimate. This is a 9.52 ...

Africa CDC Plans To Declare Regional Mpox ...
08/08/2024 15:45:04

- Bloomberg

'WHO Warns On Deadlier Strain Of Mpox' - A...
08/05/2024 16:09:25

https://www.axios.com/2024/08/05/mpox-who-warning-africaThe World Health Organization is weighing discussions on whether to dec...

Chimerix Expects Dordaviprone Interim Over...
05/01/2024 11:13:10

Dordaviprone is an oral, first-in-class small molecule imipridone that selectively binds to the G-protein coupled dopamine rece...

Chimerix Q1 2024 GAAP EPS $(0.25) Misses $...
05/01/2024 11:06:25

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by...

WHO's Tedros Adhanom Ghebreyesus Posts On ...
04/11/2024 14:09:23

https://twitter.com/DrTedros/status/1778423967105139108

HC Wainwright & Co. Reiterates Buy on Chim...
03/01/2024 12:14:30

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

Chimerix Q4 Cash and Equivalents $204M
02/29/2024 12:06:07

Chimerix Q4 EPS $(0.20) Beats $(0.24) Esti...
02/29/2024 12:05:32

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 1...

Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

Preview: Chimerix's Earnings
02/28/2024 19:01:18

Reported Earlier, "WHO 'Very Worried' Abou...
12/08/2023 17:31:10

https://www.reuters.com/business/healthcare-pharmaceuticals/who-very-worried-about-spread-mpox-drc-2023-12-08/?taid=65734f21df0...

Chimerix Announced The Promotion Of Michel...
12/04/2023 12:17:53